SCOPUS 정보 검색 플랫폼

Volumn 6, Issue 10, 2000, Pages 4154-4157

Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft

(9) Patel, Vikas J a Elion, Gertrude B a Houghton, Peter J b Keir, Stephen a Pegg, Anthony E d Johnson, Stewart P a Dolan, M Eileen c Bigner, Darell D a Friedman, Henry S a

a DUKE UNIVERSITY MEDICAL CENTER (United States)

b ST JUDE CHILDREN S RESEARCH HOSPITAL (United States)

c UNIVERSITY OF CHICAGO (United States)

d PENN STATE MILTON S HERSHEY MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRINOTECAN; TEMOZOLOMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENTIATION; FEMALE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; DACARBAZINE; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NERVOUS SYSTEM NEOPLASMS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0033760405 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (66)

References (20)

1
- 0028075307
- The basis for current treatment recommendations for malignant gliomas
- (1994) J. Neurooncol , vol.20 , pp. 11-20
- Fine, H.A.¹

2
- 0034629477
- Gene therapist, healthy self
- (2000) Science (Washington DC) , vol.287 , pp. 1751
- Rosenberg, L.E.¹ Shechter, A.N.²

3
- 0029011186
- Activity of temozolomide in the treatment of central nervous system tumor xenografts
- (1995) Cancer Res , vol.55 , pp. 2853-2857
- Friedman, H.S.¹ Dolan, M.E.² Pegg, A.E.³ Marcelli, S.⁴ Keir, S.⁵ Catino, J.J.⁶ Bigner, D.D.⁷ Schold, S.C.⁸

4
- 0031060230
- Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system xenografts
- (1997) Cancer Chemother. Pharmacol , vol.39 , pp. 187-191
- Hare, C.B.¹ Elion, G.B.² Houghton, P.J.³ Houghton, J.A.⁴ Keir, S.⁵ Marcelli, S.L.⁶ Bigner, D.D.⁷ Friedman, H.S.⁸

5
- 0032945307
- Irinotecan therapy in adults with recurrent or progressive malignant glioma
- (1999) J. Clin. Oncol , vol.17 , pp. 1516-1525
- Friedman, H.S.¹ Petros, W.P.² Friedman, A.H.³ Schaaf, L.J.⁴ Kerby, T.⁵ Lawyer, J.⁶ Parry, M.⁷ Houghton, P.J.⁸ Lovell, S.⁹ Rasheed, K.¹⁰ Cloughsey, T.¹¹ Stewart, E.S.¹² Colvin, O.M.¹³ Provenzale, J.M.¹⁴ McLendon, R.E.¹⁵ Bigner, D.D.¹⁶ Cokgor, I.¹⁷ Haglund, M.¹⁸ Rich, J.¹⁹ Ashley, D.²⁰ more..

6
- 0032855728
- Multicenter Phase II trial of temozolomide in patients with malignant astrocytoma at first relapse
- (1999) J. Clin. Oncol , vol.17 , pp. 2762-2769
- Yung, A.¹ Prados, M.² Poisson, M.³ Rosenfeld, S.⁴ Brada, M.⁵ Friedman, H.⁶ Albright, R.⁷ Friedman, A.H.⁸ Olson, J.⁹ Bruner, J.¹⁰ Yue, N.¹¹ Dugan, M.¹² Levin, V.¹³

7
- 0030993717
- Temozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trial
- (1997) Cancer Treat. Rev , vol.23 , pp. 35-61
- Newlands, E.S.¹ Stevens, M.F.G.² Wedge, S.R.³ Wheelhouse, R.T.⁴ Brock, C.⁵

8
- 0027447420
- The current status of camptothecin analogues as antitumor agents
- (1993) J. Natl. Cancer Inst , vol.85 , pp. 271-291
- Slichenmyer, W.J.¹ Rowinsky, E.K.² Donehower, R.C.³ Kaufmann, S.H.⁴

9
- 0031913229
- Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents
- (1998) Cancer Chemother. Pharmacol , vol.41 , pp. 485-490
- Coggins, C.A.¹ Elion, G.B.² Houghton, P.J.³ Hare, C.B.⁴ Keir, S.⁵ Colvin, O.M.⁶ Bigner, D.D.⁷ Friedman, H.S.⁸

10
- 0034017444
- Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts
- (2000) Cancer Chemother. Pharmacol , vol.45 , pp. 345-349
- Friedman, H.S.¹ Castellino, R.C.² Elion, G.B.³ Keir, S.T.⁴ Houghton, P.J.⁵ Johnson, S.P.⁶ Bigner, D.D.⁷

11
- 0018742909
- The heterotransplantation of human carniopharyngiomas in athymic 'nude' mice
- (1979) Neurosurgery , vol.4 , pp. 308-314
- Bullard, D.E.¹ Bigner, D.D.²

12
- 0028206027
- Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenografts
- (1994) Cancer Chemother. Pharmacol , vol.34 , pp. 171-174
- Friedman, H.S.¹ Houghton, P.J.² Schold, S.C.³ Keir, S.⁴ Bigner, D.D.⁵

13
- 0023731771
- Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents
- (1988) Cancer Res , vol.48 , pp. 4189-4195
- Friedman, H.S.¹ Colvin, O.M.² Skapek, S.X.³ Ludeman, S.M.⁴ Elion, G.B.⁵ Schold, S.C.⁶ Jacobsen, P.F.⁷ Muhlbaier, L.H.⁸ Bigner, D.D.⁹

14
- 0022647286
- Chemotherapy of subcutaneous and intracranial human medulloblastoma xenografts in athymic nude mice
- (1986) Cancer Res , vol.46 , pp. 224-228
- Friedman, H.S.¹ Schold, S.C.² Bigner, D.D.³

15
- 0002620999
- Principles of cancer management: Chemotherapy
- V. T. DeVita Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott-Raven
- (1997) , pp. 333-348
- DeVita, V.T.¹

16
- 0033897173
- A Phase II study of temozolomide versus procarbazine in patients with glioblastoma multiforme at first relapse
- in press
- (2000) Br. J. Cancer
- Yung, W.K.A.¹ Albright, R.E.² Olson, J.³ Fredericks, R.⁴ Fink, K.⁵ Prados, M.⁶ DeVita Brada, M.⁷ Spence, A.⁸ Hohl, R.J.⁹ Shapiro, W.¹⁰ Glantz, M.¹¹ Greenberg, H.¹² Selker, R.G.¹³ Vick, N.A.¹⁴ Rampling, R.¹⁵ Friedman, H.¹⁶ Phillips, P.¹⁷ Bruner, P.¹⁸ Yue, N.¹⁹ Osoba, D.²⁰ Zaknoen, S.²¹ Levin, V.A.²² more..

17
- 0033941733
- Temozolomide and malignant glioma
- (2000) Clin. Cancer Res , vol.6 , pp. 2585-2597
- Friedman, H.S.¹ Kerby, T.² Calvert, H.³

18
- 0025116511
- DNA alkylation by the haloethylnitrosoureas: Nature of modifications produced and their enzymatic repair or removal
- (1990) Mutat. Res , vol.233 , pp. 117-126
- Ludlum, D.B.¹

19
- 0001548674
- 6-Alkylation of guanine induces topoisomerase I-DNA covalent complexes in vitro and in MNNG-treated cells
- (2000) Proc. Am. Assoc. Cancer Res , vol.41 , pp. 426
- Pourquier, P.¹ Loktionova, N.A.² Pegg, A.E.³ Pommier, Y.⁴

20
- 0001155073
- 6-Methylguanine-DNA methyltransferase is a critical determinant of cytotoxicity for DNA topoisomerase I inhibitors
- (2000) Proc. Am. Assoc. Cancer Res , vol.41 , pp. 179
- Sekikawa, T.¹ Takano, H.² Okamura, T.³ Sasaki, M.⁴ Kumazaki, T.⁵ Nishiyama, M.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.